Narasimhan's Culture Club On Song At Novartis
Executive Summary
Taking over at the Swiss firm as CEO in 2018, Vas Narasimhan set about creating an "inspired, curious and unbossed organization." Two years on, he has put the spotlight on several initiatives that are up and running on a number of fronts to achieve that goal.
You may also be interested in...
Transforming Patient Engagement At Novartis
Rising Leader Yolanda Tibbe, Novartis’s head of new commercial partnerships in Germany, talks about transformation at the Swiss big pharma and how to put ‘patients as customers’ thinking into action.
PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
Dr Vas Narasimhan, a self-proclaimed history geek, is the current head of global development for Novartis Pharmaceuticals but he still considers himself a physician first when it comes to decision making.
Partner Or Go It Alone? TG Therapeutics Ponders EU Plans For Briumvi
TG Therapeutics has successfully launched Briumvi on its own in the US, despite fierce competition from established same-class MS drugs Ocrevus and Kesimpta, but is still weighing up the pros and cons of partnering for the European market.